These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 12244784

  • 1. [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].
    Ferrer Cañabate J, Tovar I, Martínez P.
    An Med Interna; 2002 Aug; 19(8):385-88. PubMed ID: 12244784
    [No Abstract] [Full Text] [Related]

  • 2. [Merger of bone biology and immunology].
    Suda T, Shima N, Higashio K.
    Tanpakushitsu Kakusan Koso; 2002 Oct; 47(13):1837-43. PubMed ID: 12385106
    [No Abstract] [Full Text] [Related]

  • 3. The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss.
    Yeung RS.
    J Rheumatol; 2004 May; 31(5):844-6. PubMed ID: 15124240
    [No Abstract] [Full Text] [Related]

  • 4. Crystal structure of RANK ligand involved in bone metabolism.
    Ito S, Hata T.
    Vitam Horm; 2004 May; 67():19-33. PubMed ID: 15110169
    [Abstract] [Full Text] [Related]

  • 5. [Molecular mechanism of bone metabolism].
    Kotake S, Utagawa N, Suda T, Kamatani N.
    Nihon Naika Gakkai Zasshi; 2000 Oct 10; 89(10):2046-53. PubMed ID: 11215116
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P.
    Circ Res; 2004 Nov 26; 95(11):1046-57. PubMed ID: 15564564
    [Abstract] [Full Text] [Related]

  • 7. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
    Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D.
    Cytokine Growth Factor Rev; 2004 Dec 26; 15(6):457-75. PubMed ID: 15561602
    [Abstract] [Full Text] [Related]

  • 8. [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].
    Hofbauer LC, Heufelder AE.
    Dtsch Med Wochenschr; 2001 Feb 09; 126(6):145-50. PubMed ID: 11233883
    [No Abstract] [Full Text] [Related]

  • 9. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
    Tanaka S, Nakamura K, Takahasi N, Suda T.
    Immunol Rev; 2005 Dec 09; 208():30-49. PubMed ID: 16313339
    [Abstract] [Full Text] [Related]

  • 10. Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
    Hofbauer LC, Heufelder AE, Erben RG.
    J Rheumatol; 2001 Apr 09; 28(4):685-7. PubMed ID: 11327234
    [No Abstract] [Full Text] [Related]

  • 11. Osteoclast precursors, RANKL/RANK, and immunology.
    Xing L, Schwarz EM, Boyce BF.
    Immunol Rev; 2005 Dec 09; 208():19-29. PubMed ID: 16313338
    [Abstract] [Full Text] [Related]

  • 12. [Recent advance in basic research for osteoporosis].
    Suda T, Miyaura C.
    Nihon Rinsho; 2004 Feb 09; 62 Suppl 2():13-20. PubMed ID: 15035090
    [No Abstract] [Full Text] [Related]

  • 13. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC, Crotti TN, Goldring SR, Gravallese EM.
    Immunol Rev; 2005 Dec 09; 208():228-51. PubMed ID: 16313352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S, Kiyokawa A, Nagayama Y.
    Clin Calcium; 2005 Jan 09; 15(1):35-42. PubMed ID: 15632471
    [Abstract] [Full Text] [Related]

  • 17. Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism.
    Hofbauer LC.
    Eur J Endocrinol; 1999 Sep 09; 141(3):195-210. PubMed ID: 10474114
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.